Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, is ...

WALTHAM, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology ...

A mother and her 3-year-old son were found dead in a car outside their Quakertown home, the Bucks County Coroner’s Office ...

AnaptysBio offers significant upside, with fair value estimates nearly double its current market cap if RA approval is ...

PDUFA date of June 13th 2025 by which FDA will decide upon whether or not UGN-102 should be approved for patients with ...

The spinout, dubbed Antares Therapeutics, will be fueled by a $177 million series A round co-led by Omega Funds, Atlas ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of ...

Is the long-awaited cure for cancer right around the corner? While the insidious disease continues to plague millions ...

Behind the veneer of accessibility lies a critical bottleneck in clinical trial readiness, especially pronounced in trials ...

Josh Carpenter discusses strategies for uniting clinical expertise, research and commercial interests at his new leadership ...

Cure Rare Disease (CRD), a clinical-stage nonprofit biotechnology organization developing genetic therapies for ultra-rare conditions, is proud to announce the appointment of Keith Sutton, PhD, as ...